Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Sustained release tablet comprising loratadine, ibuprofen and pseudoephedrine

US Patent 5100675 · Granted Mar 31, 1992

Estimated economic value: $59,768,000

Assignee

Inventors

View full patent text on Google Patents →